BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Clinical ink - ECPv6.11.2.1//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://www.clinicalink.com X-WR-CALDESC:Events for Clinical ink REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:UTC BEGIN:STANDARD TZOFFSETFROM:+0000 TZOFFSETTO:+0000 TZNAME:UTC DTSTART:20250101T000000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;VALUE=DATE:20250610 DTEND;VALUE=DATE:20250613 DTSTAMP:20250501T131743 CREATED:20250307T143024Z LAST-MODIFIED:20250307T143324Z UID:20278-1749513600-1749772799@www.clinicalink.com SUMMARY:PCMG25 DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/pcmg25/ LOCATION:Higueron Hotel Málaga\, Spain CATEGORIES:Industry Events ATTACH;FMTTYPE=image/png:https://www.clinicalink.com/wp-content/uploads/2025/03/PCMG25.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20250714 DTEND;VALUE=DATE:20250717 DTSTAMP:20250501T131743 CREATED:20250321T131613Z LAST-MODIFIED:20250321T131652Z UID:20333-1752451200-1752710399@www.clinicalink.com SUMMARY:3rd Annual Obesity & Weight Loss Drug Development Summit DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/obesity-and-weight-loss-drug-development-summit-2025/ LOCATION:Boston\, Massachusetts CATEGORIES:Industry Events ATTACH;FMTTYPE=image/png:https://www.clinicalink.com/wp-content/uploads/2025/03/3rd-obesity-and-weight-loss-drug-development-summit-.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20250923 DTEND;VALUE=DATE:20250925 DTSTAMP:20250501T131743 CREATED:20250307T144259Z LAST-MODIFIED:20250307T144325Z UID:20287-1758585600-1758758399@www.clinicalink.com SUMMARY:13th Annual Outsourcing in Clinical Trials Southern California 2025 (OCT Southern California) DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/oct-southern-california-2025/ LOCATION:Hyatt Regency La Jolla at Aventine\, San Diego\, USA CATEGORIES:Industry Events ATTACH;FMTTYPE=image/webp:https://www.clinicalink.com/wp-content/uploads/2025/03/oct-southern-california-2025.webp END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20251014 DTEND;VALUE=DATE:20251016 DTSTAMP:20250501T131743 CREATED:20250321T132635Z LAST-MODIFIED:20250321T132635Z UID:20358-1760400000-1760572799@www.clinicalink.com SUMMARY:SCOPE Europe 2025 DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/scope-europe-2025/ LOCATION:Barcelona\, Spain CATEGORIES:Industry Events ATTACH;FMTTYPE=image/png:https://www.clinicalink.com/wp-content/uploads/2025/03/scope-europe-2025.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20251015 DTEND;VALUE=DATE:20251017 DTSTAMP:20250501T131743 CREATED:20250321T133925Z LAST-MODIFIED:20250321T133956Z UID:20316-1760486400-1760659199@www.clinicalink.com SUMMARY:Outsourcing in Clinical Trials New England 2025 DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/oct-new-england-2025/ LOCATION:Boston\, Massachusetts CATEGORIES:Industry Events ATTACH;FMTTYPE=image/webp:https://www.clinicalink.com/wp-content/uploads/2025/03/oct-new-england-2025.webp END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20251021 DTEND;VALUE=DATE:20251023 DTSTAMP:20250501T131743 CREATED:20250312T164302Z LAST-MODIFIED:20250312T164316Z UID:20334-1761004800-1761177599@www.clinicalink.com SUMMARY:13th Annual Outsourcing in Clinical Trials Nordics 2025 (OCT Nordics) DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/oct-nordics-2025/ LOCATION:Copenhagen\, Denmark CATEGORIES:Industry Events ATTACH;FMTTYPE=image/webp:https://www.clinicalink.com/wp-content/uploads/2025/03/13th-annual-outsourcing-in-clinical-trials-nordics-2025.webp END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20251112 DTEND;VALUE=DATE:20251114 DTSTAMP:20250501T131743 CREATED:20250312T162626Z LAST-MODIFIED:20250312T163656Z UID:20317-1762905600-1763078399@www.clinicalink.com SUMMARY:8th Annual Outsourcing in Clinical Trials DACH 2025 (OCT DACH) DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/oct-dach-2025/ LOCATION:Zurich\, Switzerland CATEGORIES:Industry Events ATTACH;FMTTYPE=image/webp:https://www.clinicalink.com/wp-content/uploads/2025/03/8th-Annual-Outsourcing-in-Clinical-Trials-DACH-2025.webp END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20251118 DTEND;VALUE=DATE:20251120 DTSTAMP:20250501T131743 CREATED:20250312T163521Z LAST-MODIFIED:20250312T163534Z UID:20323-1763424000-1763596799@www.clinicalink.com SUMMARY:3rd Annual Clinical Outsourcing Group Europe - COG Europe DESCRIPTION:The challenges and importance of patient adherence to treatment have been recognized for decades and reinforced by World Health Organization (WHO) reports. Similarly\, treatment adherence and engagement in study protocols are critical for clinical trial success. Every research participant who discontinues study drug\, fails to provide clinical data\, or drops out of a study\, reduces its statistical power\, and may bias the results\, impacting credibility.  In this webinar\, the expert speakers will discuss the importance of adherence in both clinical practice and in the drug development setting. The expert speakers will examine key evidence-based frameworks for understanding and improving adherence to prescribed treatment as well as protocol engagement\, and they will highlight the ways in which digital resources and artificial intelligence can leverage these frameworks to increase success in clinical practice and research. Treatment adherence and engagement in clinical trials do respond to intervention. While digital solutions are extremely useful\, effective approaches should apply the findings from behavioral science\, which advance our understanding of patients’ experience with chronic disease and suggest solutions. Whether in clinical practice or a research trial\, a valid assessment of patients’ beliefs\, attitudes and behaviors allows for rational and personalized interventions\, including solutions using digital tools. Register for this webinar today to explore how evidence-based behavioral frameworks\, digital tools and AI can improve patient adherence and engagement in both clinical practice and clinical trials. \n \n \n \n \n \n \n Register Now URL:https://www.clinicalink.com/event/cog-europe-2025/ LOCATION:Amsterdam\, Netherlands CATEGORIES:Industry Events ATTACH;FMTTYPE=image/jpeg:https://www.clinicalink.com/wp-content/uploads/2025/03/max-van-den-oetelaar-e4vLFZV9QM-unsplash-scaled.jpg END:VEVENT END:VCALENDAR